163 related articles for article (PubMed ID: 26701852)
21. MicroRNA-155 promotes bladder cancer growth by repressing the tumor suppressor DMTF1.
Peng Y; Dong W; Lin TX; Zhong GZ; Liao B; Wang B; Gu P; Huang L; Xie Y; Lu FD; Chen X; Xie WB; He W; Wu SX; Huang J
Oncotarget; 2015 Jun; 6(18):16043-58. PubMed ID: 25965824
[TBL] [Abstract][Full Text] [Related]
22. Genomic loss of EZH2 leads to epigenetic modifications and overexpression of the HOX gene clusters in myelodysplastic syndrome.
Xu F; Liu L; Chang CK; He Q; Wu LY; Zhang Z; Shi WH; Guo J; Zhu Y; Zhao YS; Gu SC; Fei CM; Li X
Oncotarget; 2016 Feb; 7(7):8119-30. PubMed ID: 26812882
[TBL] [Abstract][Full Text] [Related]
23. Involvement of epigenetics and microRNA-29b in the urethane induced inception and establishment of mouse lung tumors.
Pandey M; Sultana S; Gupta KP
Exp Mol Pathol; 2014 Feb; 96(1):61-70. PubMed ID: 24361357
[TBL] [Abstract][Full Text] [Related]
24. Downregulation of miR-132 by promoter methylation contributes to pancreatic cancer development.
Zhang S; Hao J; Xie F; Hu X; Liu C; Tong J; Zhou J; Wu J; Shao C
Carcinogenesis; 2011 Aug; 32(8):1183-9. PubMed ID: 21665894
[TBL] [Abstract][Full Text] [Related]
25. Regulation of connexin 43 and microRNA expression via β2-adrenoceptor signaling in 1321N1 astrocytoma cells.
Khaksarian M; Mostafavi H; Soleimani M; Karimian SM; Ghahremani MH; Joghataee MT; Khorashadizadeh M; Aligholi H; Attari F; Hassanzadeh G
Mol Med Rep; 2015 Aug; 12(2):1941-50. PubMed ID: 25873300
[TBL] [Abstract][Full Text] [Related]
26. Hsa-miR-326 targets CCND1 and inhibits non-small cell lung cancer development.
Sun C; Huang C; Li S; Yang C; Xi Y; Wang L; Zhang F; Fu Y; Li D
Oncotarget; 2016 Feb; 7(7):8341-59. PubMed ID: 26840018
[TBL] [Abstract][Full Text] [Related]
27. miR-192, a prognostic indicator, targets the SLC39A6/SNAIL pathway to reduce tumor metastasis in human hepatocellular carcinoma.
Lian J; Jing Y; Dong Q; Huan L; Chen D; Bao C; Wang Q; Zhao F; Li J; Yao M; Qin L; Liang L; He X
Oncotarget; 2016 Jan; 7(3):2672-83. PubMed ID: 26684241
[TBL] [Abstract][Full Text] [Related]
28. Human positive coactivator 4 (PC4) is involved in the progression and prognosis of astrocytoma.
Chen L; Du C; Wang L; Yang C; Zhang JR; Li N; Li Y; Xie XD; Gao GD
J Neurol Sci; 2014 Nov; 346(1-2):293-8. PubMed ID: 25262015
[TBL] [Abstract][Full Text] [Related]
29. Promoter hypermethylation-mediated down-regulation of CXCL12 in human astrocytoma.
Zhou W; Jiang Z; Song X; Liu Y; Wen P; Guo Y; Xu F; Kong L; Zhang P; Han A; Yu J
J Neurosci Res; 2008 Oct; 86(13):3002-10. PubMed ID: 18512766
[TBL] [Abstract][Full Text] [Related]
30. Wip1 over-expression correlated with TP53/p14(ARF) pathway disruption in human astrocytomas.
Wang P; Rao J; Yang H; Zhao H; Yang L
J Surg Oncol; 2011 Nov; 104(6):679-84. PubMed ID: 21695702
[TBL] [Abstract][Full Text] [Related]
31. p53-dependent activation of microRNA-34a in response to etoposide-induced DNA damage in osteosarcoma cell lines not impaired by dominant negative p53 expression.
Novello C; Pazzaglia L; Conti A; Quattrini I; Pollino S; Perego P; Picci P; Benassi MS
PLoS One; 2014; 9(12):e114757. PubMed ID: 25490093
[TBL] [Abstract][Full Text] [Related]
32. RASSF10 is an epigenetically inactivated tumor suppressor and independent prognostic factor in hepatocellular carcinoma.
Wang F; Feng Y; Li P; Wang K; Feng L; Liu YF; Huang H; Guo YB; Mao QS; Xue WJ
Oncotarget; 2016 Jan; 7(4):4279-97. PubMed ID: 26701853
[TBL] [Abstract][Full Text] [Related]
33. Role of PRDM16 and its PR domain in the epigenetic regulation of myogenic and adipogenic genes during transdifferentiation of C2C12 cells.
Li X; Wang J; Jiang Z; Guo F; Soloway PD; Zhao R
Gene; 2015 Oct; 570(2):191-8. PubMed ID: 26071185
[TBL] [Abstract][Full Text] [Related]
34. miR675 upregulates long noncoding RNA H19 through activating EGR1 in human liver cancer.
Li H; Li J; Jia S; Wu M; An J; Zheng Q; Zhang W; Lu D
Oncotarget; 2015 Oct; 6(31):31958-84. PubMed ID: 26376677
[TBL] [Abstract][Full Text] [Related]
35. Hyperhomocysteinemia associated skeletal muscle weakness involves mitochondrial dysfunction and epigenetic modifications.
Veeranki S; Winchester LJ; Tyagi SC
Biochim Biophys Acta; 2015 May; 1852(5):732-41. PubMed ID: 25615794
[TBL] [Abstract][Full Text] [Related]
36. Effect of miR-20b on Apoptosis, Differentiation, the BMP Signaling Pathway and Mitochondrial Function in the P19 Cell Model of Cardiac Differentiation In Vitro.
Zhu S; Hu X; Yu Z; Peng Y; Zhu J; Liu X; Li M; Han S; Zhu C
PLoS One; 2015; 10(4):e0123519. PubMed ID: 25898012
[TBL] [Abstract][Full Text] [Related]
37. Promoter hypermethylation-mediated down-regulation of LATS1 and LATS2 in human astrocytoma.
Jiang Z; Li X; Hu J; Zhou W; Jiang Y; Li G; Lu D
Neurosci Res; 2006 Dec; 56(4):450-8. PubMed ID: 17049657
[TBL] [Abstract][Full Text] [Related]
38. The putative tumor suppressor miR-524-5p directly targets Jagged-1 and Hes-1 in glioma.
Chen L; Zhang W; Yan W; Han L; Zhang K; Shi Z; Zhang J; Wang Y; Li Y; Yu S; Pu P; Jiang C; Jiang T; Kang C
Carcinogenesis; 2012 Nov; 33(11):2276-82. PubMed ID: 22871495
[TBL] [Abstract][Full Text] [Related]
39. Increased heparanase expression is caused by promoter hypomethylation and up-regulation of transcriptional factor early growth response-1 in human prostate cancer.
Ogishima T; Shiina H; Breault JE; Tabatabai L; Bassett WW; Enokida H; Li LC; Kawakami T; Urakami S; Ribeiro-Filho LA; Terashima M; Fujime M; Igawa M; Dahiya R
Clin Cancer Res; 2005 Feb; 11(3):1028-36. PubMed ID: 15709168
[TBL] [Abstract][Full Text] [Related]
40. microRNA-1827 represses MDM2 to positively regulate tumor suppressor p53 and suppress tumorigenesis.
Zhang C; Liu J; Tan C; Yue X; Zhao Y; Peng J; Wang X; Laddha SV; Chan CS; Zheng S; Hu W; Feng Z
Oncotarget; 2016 Feb; 7(8):8783-96. PubMed ID: 26840028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
